Exploring skin lesion assessments in adults with certain skin conditions
A Pilot Cohort Study of Risk Factors and Novel Methods of Skin Lesion Assessments in Adults With Atopic Dermatitis, Alopecia Areata, Psoriasis or Vitiligo / Et Pilot-kohortestudie om Risikofaktorer og Nye Metoder Til at Vurdere hudlæsioner Hos Voksne Med Atopisk Dermatitis, Alopecia Areata, Psoriasis Eller Vitiligo
Blueskin AS · NCT06319781
This study is testing if smartphone photos can help doctors better understand and track the severity of skin conditions like atopic dermatitis, alopecia areata, psoriasis, and vitiligo in about 370 adults over a year.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 370 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Blueskin AS (industry) |
| Locations | 3 sites (Gandrup and 2 other locations) |
| Trial ID | NCT06319781 on ClinicalTrials.gov |
What this trial studies
This observational study aims to investigate clinical and biochemical factors associated with the severity and prognosis of atopic dermatitis, alopecia areata, psoriasis, and vitiligo. It will validate the use of smartphone-acquired photos for remote assessments of skin lesions and evaluate patient compliance with weekly data collection over one year. The study will involve approximately 370 patients and will collect serum samples and perform punch biopsies to explore potential biomarkers related to these conditions.
Who should consider this trial
Good fit: Ideal candidates include adults over 18 with a physician-diagnosed skin condition among atopic dermatitis, psoriasis, vitiligo, or alopecia areata who can provide weekly smartphone photos of their lesions.
Not a fit: Patients with physical attributes or skin conditions that may interfere with lesion evaluation, or those with recent malignant diseases, may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of skin conditions and improve remote monitoring and management strategies for patients.
How similar studies have performed: While this approach is innovative, similar studies have shown promise in using remote assessments for chronic skin conditions.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult subjects \>18 years of age at screening. * Previous diagnosis by a physician of atopic dermatitis, psoriasis, vitiligo, or alopecia areata. * Visible lesions and willingness to photograph weekly using their smartphone * Availability of a smartphone Exclusion Criteria: * Has any physical attributes or skin conditions that in the opinion of the investigator might interfere with the evaluation of lesions (i.e., pigmentation, tattoos, extensive scarring, excessive hair growth or acne) * Has other clinically relevant illness that could interfere with healing of lesions (e.g. keloid scaring) * Current or previous malignant disease, including malignant melanoma and basal cell carcinoma, within 5 years * Some patients may have more than one of the four conditions. This is not an exclusion criterion per se but must be recorded.
Where this trial is running
Gandrup and 2 other locations
- Sanos Clinic, Gandrup — Gandrup, Denmark (RECRUITING)
- Sanos Clinic, Herlev — Herlev, Denmark (RECRUITING)
- Sanos Clinic, Vejle — Vejle, Denmark (RECRUITING)
Study contacts
- Principal investigator: Zarqa Ali, MD, PhD — Bispebjerg Hospital
- Study coordinator: Alejandro Castillo Mondragón, MD
- Email: amo@nbcd.com
- Phone: +4550376106
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Alopecia Areata, Vitiligo, Atopic Dermatitis, Psoriasis